<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>For patients with <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> refractory to intensive chemotherapy prognosis is very poor and treatment options are limited </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="2038">5-Azacytidine</z:chebi>, a demethylating drug, is effective in the treatment of <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> when administered at a low-dose, subcutaneously </plain></SENT>
<SENT sid="2" pm="."><plain>We report a case of a patient with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> refractory to induction chemotherapy as well as to two high-dose salvage regimens </plain></SENT>
<SENT sid="3" pm="."><plain>The patient achieved CR through monotherapy with low-dose azacytidine </plain></SENT>
</text></document>